Rosmarinic Acid Down-Regulates the LPS-Induced Production of Monocyte Chemoattractant Protein-1 (MCP-1) and Macrophage Inflammatory Protein-1α (MIP-1α) via the MAPK Pathway in Bone-Marrow Derived Dendritic Cells

• Published in: Molecules and cells 2008-12, Vol.26 (6), p.583-589
• Main Authors: Kim, H.K. (Chonnam National University, Hwasun Hospital, Hwasun, Republic of Korea), Lee, J.J. (Chonnam National University, Hwasun Hospital, Hwasun, Republic of Korea), Lee, J.S. (Pusan National University, Busan, Republic of Korea), Park, Y.M. (Pusan National University, Busan, Republic of Korea), Yoon, T.R. (Chonnam National University, Hwasun Hospital, Hwasun, Republic of Korea), E-mail: [e-mail]
• Format: Article
• Language: English
• Subjects: CELLS; CELLULE; CELULAS; dendritic cells; MAPK pathway; MCP-1; MIP-1 alpha; Rosmarinic acid
• ISSN: 1016-8478
• DOI: 10.1016/S1016-8478(23)25236-X

In the present study, we investigated whether rosmarinic acid, which has been suggested to exhibit anti-inflammatory properties, can suppress the expressions of monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α) via the MAPK pathway in LPS-stimulated bone marrow-derived dendritic cells (BMDCs) in the presence of GM-CSF and IL-4 in media. The effects of rosmarinic acid were investigated in BMDCs with respect to the following; cytotoxicity, surface molecule expression, dextran-FITC uptake, cell migration, chemokine gene expression, and the MAPK signaling pathway. Rosmarinic acid was found to significantly inhibit the expressions of CD80, CD86, MHC class Ⅰ, and MHC class Ⅱ in LPS-stimulated mature BMDCs, and rosmarinic acid-treated BMDCs were found to be highly efficient with regards to antigen capture via mannose receptor-mediated endocytosis. In addition, rosmarinic acid reduced cell migration by inducing the expression of a specific chemokine receptor on LPS-induced mature BMDCs. Rosmarinic acid also significantly reduced the expressions of MCP-1 and MIP-1α induced by LPS in BMDCs and inhibited LPS-induced activation of MAPK and the nuclear translocation of NF-κB. These findings broaden current perspectives concerning our understanding of the immunopharmacological functions of rosmarinic acid, and have ramifications that concern the development of therapeutic drugs for the treatment of DC-related acute and chronic diseases.